nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—ALB—atherosclerosis	0.242	1	CbGaD
Abiraterone—ABCC1—Rosuvastatin—atherosclerosis	0.133	0.249	CbGbCtD
Abiraterone—ALB—Rosuvastatin—atherosclerosis	0.0615	0.115	CbGbCtD
Abiraterone—CYP2C8—Simvastatin—atherosclerosis	0.0442	0.0824	CbGbCtD
Abiraterone—CYP2C8—Pravastatin—atherosclerosis	0.0432	0.0807	CbGbCtD
Abiraterone—CYP2C8—Lovastatin—atherosclerosis	0.0432	0.0807	CbGbCtD
Abiraterone—CYP2D6—Niacin—atherosclerosis	0.0356	0.0665	CbGbCtD
Abiraterone—CYP2D6—Simvastatin—atherosclerosis	0.0282	0.0526	CbGbCtD
Abiraterone—CYP2D6—Lovastatin—atherosclerosis	0.0276	0.0514	CbGbCtD
Abiraterone—CYP2D6—Pravastatin—atherosclerosis	0.0276	0.0514	CbGbCtD
Abiraterone—CYP3A4—Rosuvastatin—atherosclerosis	0.0193	0.036	CbGbCtD
Abiraterone—CYP3A4—Ezetimibe—atherosclerosis	0.0193	0.036	CbGbCtD
Abiraterone—CYP3A4—Simvastatin—atherosclerosis	0.0179	0.0334	CbGbCtD
Abiraterone—CYP3A4—Lovastatin—atherosclerosis	0.0175	0.0327	CbGbCtD
Abiraterone—CYP3A4—Pravastatin—atherosclerosis	0.0175	0.0327	CbGbCtD
Abiraterone—Hepatotoxicity—Niacin—atherosclerosis	0.00189	0.0195	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.0017	0.0176	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00166	0.0172	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00159	0.0164	CcSEcCtD
Abiraterone—Nocturia—Pravastatin—atherosclerosis	0.00155	0.016	CcSEcCtD
Abiraterone—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.00143	0.0149	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00142	0.0147	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00139	0.0144	CcSEcCtD
Abiraterone—Fluid retention—Niacin—atherosclerosis	0.00138	0.0143	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00132	0.0137	CcSEcCtD
Abiraterone—Hot flush—Ezetimibe—atherosclerosis	0.00129	0.0134	CcSEcCtD
Abiraterone—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00128	0.0133	CcSEcCtD
Abiraterone—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.0012	0.0124	CcSEcCtD
Abiraterone—Hot flush—Pravastatin—atherosclerosis	0.00111	0.0115	CcSEcCtD
Abiraterone—Menopausal symptoms—Pravastatin—atherosclerosis	0.0011	0.0114	CcSEcCtD
Abiraterone—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00109	0.0113	CcSEcCtD
Abiraterone—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00109	0.0113	CcSEcCtD
Abiraterone—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00108	0.0112	CcSEcCtD
Abiraterone—Haematuria—Rosuvastatin—atherosclerosis	0.00107	0.0111	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00107	0.011	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00097	0.01	CcSEcCtD
Abiraterone—Nasopharyngitis—Pravastatin—atherosclerosis	0.000931	0.00964	CcSEcCtD
Abiraterone—Infestation NOS—Ezetimibe—atherosclerosis	0.000931	0.00964	CcSEcCtD
Abiraterone—Infestation—Ezetimibe—atherosclerosis	0.000931	0.00964	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000925	0.00958	CcSEcCtD
Abiraterone—Urinary tract infection—Lovastatin—atherosclerosis	0.000923	0.00955	CcSEcCtD
Abiraterone—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000919	0.00951	CcSEcCtD
Abiraterone—Arrhythmia—Rosuvastatin—atherosclerosis	0.000898	0.0093	CcSEcCtD
Abiraterone—Mental disorder—Rosuvastatin—atherosclerosis	0.000881	0.00912	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000837	0.00866	CcSEcCtD
Abiraterone—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000821	0.0085	CcSEcCtD
Abiraterone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000791	0.00819	CcSEcCtD
Abiraterone—Myocardial infarction—Pravastatin—atherosclerosis	0.000787	0.00814	CcSEcCtD
Abiraterone—Urinary tract infection—Pravastatin—atherosclerosis	0.00078	0.00808	CcSEcCtD
Abiraterone—Cough—Rosuvastatin—atherosclerosis	0.000764	0.0079	CcSEcCtD
Abiraterone—Angiopathy—Ezetimibe—atherosclerosis	0.000758	0.00785	CcSEcCtD
Abiraterone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000753	0.0078	CcSEcCtD
Abiraterone—Myalgia—Rosuvastatin—atherosclerosis	0.000745	0.00771	CcSEcCtD
Abiraterone—Mental disorder—Ezetimibe—atherosclerosis	0.000732	0.00758	CcSEcCtD
Abiraterone—Infection—Rosuvastatin—atherosclerosis	0.00071	0.00734	CcSEcCtD
Abiraterone—Mental disorder—Simvastatin—atherosclerosis	0.000698	0.00723	CcSEcCtD
Abiraterone—Anaemia—Ezetimibe—atherosclerosis	0.000672	0.00696	CcSEcCtD
Abiraterone—Cardiac disorder—Pravastatin—atherosclerosis	0.000669	0.00692	CcSEcCtD
Abiraterone—Angiopathy—Niacin—atherosclerosis	0.000664	0.00687	CcSEcCtD
Abiraterone—Arrhythmia—Niacin—atherosclerosis	0.000654	0.00677	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000651	0.00674	CcSEcCtD
Abiraterone—Insomnia—Rosuvastatin—atherosclerosis	0.000646	0.00669	CcSEcCtD
Abiraterone—Arrhythmia—Pravastatin—atherosclerosis	0.000644	0.00666	CcSEcCtD
Abiraterone—Anaemia—Simvastatin—atherosclerosis	0.000641	0.00664	CcSEcCtD
Abiraterone—Cough—Ezetimibe—atherosclerosis	0.000635	0.00657	CcSEcCtD
Abiraterone—Chest pain—Lovastatin—atherosclerosis	0.000631	0.00654	CcSEcCtD
Abiraterone—Myalgia—Lovastatin—atherosclerosis	0.000631	0.00654	CcSEcCtD
Abiraterone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000629	0.00651	CcSEcCtD
Abiraterone—Hypertension—Ezetimibe—atherosclerosis	0.000628	0.0065	CcSEcCtD
Abiraterone—Discomfort—Lovastatin—atherosclerosis	0.000624	0.00646	CcSEcCtD
Abiraterone—Myalgia—Ezetimibe—atherosclerosis	0.000619	0.00641	CcSEcCtD
Abiraterone—Chest pain—Ezetimibe—atherosclerosis	0.000619	0.00641	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000615	0.00637	CcSEcCtD
Abiraterone—Discomfort—Ezetimibe—atherosclerosis	0.000612	0.00633	CcSEcCtD
Abiraterone—Constipation—Rosuvastatin—atherosclerosis	0.000611	0.00632	CcSEcCtD
Abiraterone—Infection—Lovastatin—atherosclerosis	0.000601	0.00622	CcSEcCtD
Abiraterone—Myalgia—Simvastatin—atherosclerosis	0.000591	0.00611	CcSEcCtD
Abiraterone—Chest pain—Simvastatin—atherosclerosis	0.000591	0.00611	CcSEcCtD
Abiraterone—Infection—Ezetimibe—atherosclerosis	0.00059	0.00611	CcSEcCtD
Abiraterone—Discomfort—Simvastatin—atherosclerosis	0.000584	0.00604	CcSEcCtD
Abiraterone—Anaemia—Pravastatin—atherosclerosis	0.00058	0.006	CcSEcCtD
Abiraterone—Skin disorder—Ezetimibe—atherosclerosis	0.000577	0.00597	CcSEcCtD
Abiraterone—Oedema—Simvastatin—atherosclerosis	0.000566	0.00586	CcSEcCtD
Abiraterone—Infection—Simvastatin—atherosclerosis	0.000563	0.00582	CcSEcCtD
Abiraterone—Cough—Niacin—atherosclerosis	0.000556	0.00575	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000552	0.00571	CcSEcCtD
Abiraterone—Insomnia—Lovastatin—atherosclerosis	0.000548	0.00567	CcSEcCtD
Abiraterone—Cough—Pravastatin—atherosclerosis	0.000547	0.00567	CcSEcCtD
Abiraterone—Myalgia—Niacin—atherosclerosis	0.000542	0.00561	CcSEcCtD
Abiraterone—Hypertension—Pravastatin—atherosclerosis	0.000542	0.00561	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000541	0.0056	CcSEcCtD
Abiraterone—Dyspnoea—Lovastatin—atherosclerosis	0.00054	0.00559	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000539	0.00557	CcSEcCtD
Abiraterone—Insomnia—Ezetimibe—atherosclerosis	0.000537	0.00556	CcSEcCtD
Abiraterone—Chest pain—Pravastatin—atherosclerosis	0.000534	0.00553	CcSEcCtD
Abiraterone—Myalgia—Pravastatin—atherosclerosis	0.000534	0.00553	CcSEcCtD
Abiraterone—Dyspepsia—Lovastatin—atherosclerosis	0.000533	0.00552	CcSEcCtD
Abiraterone—Dyspnoea—Ezetimibe—atherosclerosis	0.000529	0.00548	CcSEcCtD
Abiraterone—Discomfort—Pravastatin—atherosclerosis	0.000528	0.00546	CcSEcCtD
Abiraterone—Dyspepsia—Ezetimibe—atherosclerosis	0.000523	0.00541	CcSEcCtD
Abiraterone—Fatigue—Lovastatin—atherosclerosis	0.000522	0.0054	CcSEcCtD
Abiraterone—Oedema—Niacin—atherosclerosis	0.00052	0.00538	CcSEcCtD
Abiraterone—Constipation—Lovastatin—atherosclerosis	0.000518	0.00536	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000516	0.00534	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000513	0.00531	CcSEcCtD
Abiraterone—Asthenia—Rosuvastatin—atherosclerosis	0.000512	0.0053	CcSEcCtD
Abiraterone—Insomnia—Simvastatin—atherosclerosis	0.000512	0.0053	CcSEcCtD
Abiraterone—Oedema—Pravastatin—atherosclerosis	0.000512	0.0053	CcSEcCtD
Abiraterone—Fatigue—Ezetimibe—atherosclerosis	0.000512	0.0053	CcSEcCtD
Abiraterone—Infection—Pravastatin—atherosclerosis	0.000509	0.00526	CcSEcCtD
Abiraterone—Constipation—Ezetimibe—atherosclerosis	0.000508	0.00526	CcSEcCtD
Abiraterone—Skin disorder—Niacin—atherosclerosis	0.000505	0.00523	CcSEcCtD
Abiraterone—Dyspnoea—Simvastatin—atherosclerosis	0.000505	0.00522	CcSEcCtD
Abiraterone—Dyspepsia—Simvastatin—atherosclerosis	0.000498	0.00516	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000489	0.00506	CcSEcCtD
Abiraterone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000489	0.00506	CcSEcCtD
Abiraterone—Fatigue—Simvastatin—atherosclerosis	0.000488	0.00505	CcSEcCtD
Abiraterone—Constipation—Simvastatin—atherosclerosis	0.000484	0.00501	CcSEcCtD
Abiraterone—Body temperature increased—Lovastatin—atherosclerosis	0.000479	0.00495	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000474	0.0049	CcSEcCtD
Abiraterone—Insomnia—Niacin—atherosclerosis	0.00047	0.00487	CcSEcCtD
Abiraterone—Body temperature increased—Ezetimibe—atherosclerosis	0.000469	0.00486	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000466	0.00483	CcSEcCtD
Abiraterone—Dyspnoea—Niacin—atherosclerosis	0.000464	0.0048	CcSEcCtD
Abiraterone—Insomnia—Pravastatin—atherosclerosis	0.000463	0.00479	CcSEcCtD
Abiraterone—Dyspepsia—Niacin—atherosclerosis	0.000458	0.00474	CcSEcCtD
Abiraterone—Dyspnoea—Pravastatin—atherosclerosis	0.000456	0.00472	CcSEcCtD
Abiraterone—Dyspepsia—Pravastatin—atherosclerosis	0.000451	0.00466	CcSEcCtD
Abiraterone—Rash—Rosuvastatin—atherosclerosis	0.00045	0.00466	CcSEcCtD
Abiraterone—Dermatitis—Rosuvastatin—atherosclerosis	0.00045	0.00466	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000449	0.00465	CcSEcCtD
Abiraterone—Body temperature increased—Simvastatin—atherosclerosis	0.000448	0.00463	CcSEcCtD
Abiraterone—Fatigue—Pravastatin—atherosclerosis	0.000441	0.00457	CcSEcCtD
Abiraterone—Constipation—Pravastatin—atherosclerosis	0.000438	0.00453	CcSEcCtD
Abiraterone—Asthenia—Lovastatin—atherosclerosis	0.000434	0.0045	CcSEcCtD
Abiraterone—Asthenia—Ezetimibe—atherosclerosis	0.000426	0.00441	CcSEcCtD
Abiraterone—Diarrhoea—Lovastatin—atherosclerosis	0.000414	0.00429	CcSEcCtD
Abiraterone—Body temperature increased—Niacin—atherosclerosis	0.000411	0.00425	CcSEcCtD
Abiraterone—Asthenia—Simvastatin—atherosclerosis	0.000406	0.0042	CcSEcCtD
Abiraterone—Diarrhoea—Ezetimibe—atherosclerosis	0.000406	0.0042	CcSEcCtD
Abiraterone—Body temperature increased—Pravastatin—atherosclerosis	0.000405	0.00419	CcSEcCtD
Abiraterone—Diarrhoea—Simvastatin—atherosclerosis	0.000387	0.00401	CcSEcCtD
Abiraterone—Vomiting—Lovastatin—atherosclerosis	0.000385	0.00398	CcSEcCtD
Abiraterone—Rash—Lovastatin—atherosclerosis	0.000382	0.00395	CcSEcCtD
Abiraterone—Dermatitis—Lovastatin—atherosclerosis	0.000381	0.00395	CcSEcCtD
Abiraterone—Vomiting—Ezetimibe—atherosclerosis	0.000378	0.00391	CcSEcCtD
Abiraterone—Rash—Ezetimibe—atherosclerosis	0.000374	0.00387	CcSEcCtD
Abiraterone—Dermatitis—Ezetimibe—atherosclerosis	0.000374	0.00387	CcSEcCtD
Abiraterone—Asthenia—Niacin—atherosclerosis	0.000373	0.00386	CcSEcCtD
Abiraterone—Asthenia—Pravastatin—atherosclerosis	0.000367	0.0038	CcSEcCtD
Abiraterone—Vomiting—Simvastatin—atherosclerosis	0.00036	0.00373	CcSEcCtD
Abiraterone—Rash—Simvastatin—atherosclerosis	0.000357	0.0037	CcSEcCtD
Abiraterone—Dermatitis—Simvastatin—atherosclerosis	0.000357	0.00369	CcSEcCtD
Abiraterone—Diarrhoea—Niacin—atherosclerosis	0.000356	0.00368	CcSEcCtD
Abiraterone—Diarrhoea—Pravastatin—atherosclerosis	0.00035	0.00363	CcSEcCtD
Abiraterone—Vomiting—Niacin—atherosclerosis	0.000331	0.00342	CcSEcCtD
Abiraterone—Rash—Niacin—atherosclerosis	0.000328	0.00339	CcSEcCtD
Abiraterone—Dermatitis—Niacin—atherosclerosis	0.000328	0.00339	CcSEcCtD
Abiraterone—Vomiting—Pravastatin—atherosclerosis	0.000325	0.00337	CcSEcCtD
Abiraterone—Rash—Pravastatin—atherosclerosis	0.000323	0.00334	CcSEcCtD
Abiraterone—Dermatitis—Pravastatin—atherosclerosis	0.000322	0.00334	CcSEcCtD
Abiraterone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.8e-05	0.000143	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.79e-05	0.000142	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCG1—atherosclerosis	1.78e-05	0.000141	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.78e-05	0.000141	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	1.77e-05	0.00014	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PPARG—atherosclerosis	1.76e-05	0.00014	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.74e-05	0.000138	CbGpPWpGaD
Abiraterone—ABCC1—Disease—LPL—atherosclerosis	1.74e-05	0.000138	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.73e-05	0.000138	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—INS—atherosclerosis	1.73e-05	0.000137	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOA2—atherosclerosis	1.72e-05	0.000136	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	1.72e-05	0.000136	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	1.72e-05	0.000136	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALOX15—atherosclerosis	1.72e-05	0.000136	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	1.71e-05	0.000136	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PLA2G2A—atherosclerosis	1.71e-05	0.000136	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALOX5AP—atherosclerosis	1.71e-05	0.000136	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALOX15—atherosclerosis	1.71e-05	0.000136	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOA2—atherosclerosis	1.71e-05	0.000136	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PDGFB—atherosclerosis	1.71e-05	0.000136	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.7e-05	0.000135	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.7e-05	0.000135	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PLTP—atherosclerosis	1.7e-05	0.000135	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PRKCG—atherosclerosis	1.69e-05	0.000134	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MMP1—atherosclerosis	1.69e-05	0.000134	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCG5—atherosclerosis	1.69e-05	0.000134	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.69e-05	0.000134	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LCAT—atherosclerosis	1.67e-05	0.000133	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—FABP4—atherosclerosis	1.67e-05	0.000133	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LPA—atherosclerosis	1.64e-05	0.00013	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOA4—atherosclerosis	1.64e-05	0.00013	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LPA—atherosclerosis	1.63e-05	0.000129	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—CAV1—atherosclerosis	1.62e-05	0.000129	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1.62e-05	0.000129	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—APOA1—atherosclerosis	1.62e-05	0.000128	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.61e-05	0.000128	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—HMOX1—atherosclerosis	1.59e-05	0.000126	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—BGN—atherosclerosis	1.59e-05	0.000126	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—ALB—atherosclerosis	1.59e-05	0.000126	CbGpPWpGaD
Abiraterone—ALB—Metabolism—BGN—atherosclerosis	1.58e-05	0.000125	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.58e-05	0.000125	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOA5—atherosclerosis	1.57e-05	0.000125	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.57e-05	0.000125	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.57e-05	0.000124	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MTHFR—atherosclerosis	1.57e-05	0.000124	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOA5—atherosclerosis	1.56e-05	0.000124	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—F2—atherosclerosis	1.54e-05	0.000122	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.53e-05	0.000121	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOB—atherosclerosis	1.53e-05	0.000121	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PDGFB—atherosclerosis	1.52e-05	0.000121	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NOS2—atherosclerosis	1.52e-05	0.000121	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.52e-05	0.000121	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—NOS3—atherosclerosis	1.52e-05	0.00012	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.51e-05	0.00012	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PLA2G1B—atherosclerosis	1.51e-05	0.000119	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.5e-05	0.000119	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.49e-05	0.000118	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.49e-05	0.000118	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.49e-05	0.000118	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GSTM1—atherosclerosis	1.48e-05	0.000118	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.48e-05	0.000118	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.48e-05	0.000117	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3CG—atherosclerosis	1.48e-05	0.000117	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.47e-05	0.000117	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.47e-05	0.000117	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.47e-05	0.000117	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.47e-05	0.000117	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.46e-05	0.000116	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APOE—atherosclerosis	1.46e-05	0.000116	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—LPL—atherosclerosis	1.46e-05	0.000116	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ALOX5—atherosclerosis	1.45e-05	0.000115	CbGpPWpGaD
Abiraterone—ABCC1—Disease—CAV1—atherosclerosis	1.44e-05	0.000115	CbGpPWpGaD
Abiraterone—ABCC1—Disease—APOA1—atherosclerosis	1.44e-05	0.000114	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—GPX1—atherosclerosis	1.42e-05	0.000113	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.41e-05	0.000112	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.41e-05	0.000112	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOA2—atherosclerosis	1.41e-05	0.000112	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.41e-05	0.000112	CbGpPWpGaD
Abiraterone—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.4e-05	0.000111	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.39e-05	0.000111	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—PTGS2—atherosclerosis	1.39e-05	0.00011	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CD36—atherosclerosis	1.38e-05	0.00011	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS2—atherosclerosis	1.36e-05	0.000108	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.35e-05	0.000107	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—IGF1—atherosclerosis	1.35e-05	0.000107	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LPA—atherosclerosis	1.35e-05	0.000107	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.34e-05	0.000107	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—atherosclerosis	1.31e-05	0.000104	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.31e-05	0.000104	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MTHFR—atherosclerosis	1.31e-05	0.000104	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—BGN—atherosclerosis	1.3e-05	0.000104	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NAMPT—atherosclerosis	1.3e-05	0.000104	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.3e-05	0.000103	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LIPC—atherosclerosis	1.3e-05	0.000103	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.3e-05	0.000103	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LIPC—atherosclerosis	1.3e-05	0.000103	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOC3—atherosclerosis	1.3e-05	0.000103	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOA5—atherosclerosis	1.29e-05	0.000102	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOC3—atherosclerosis	1.29e-05	0.000102	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LDLR—atherosclerosis	1.29e-05	0.000102	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPARA—atherosclerosis	1.29e-05	0.000102	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SERPINE1—atherosclerosis	1.28e-05	0.000102	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LDLR—atherosclerosis	1.28e-05	0.000102	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CETP—atherosclerosis	1.26e-05	9.98e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CETP—atherosclerosis	1.25e-05	9.92e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AGT—atherosclerosis	1.25e-05	9.89e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—INS—atherosclerosis	1.25e-05	9.88e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.24e-05	9.87e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NOS3—atherosclerosis	1.22e-05	9.72e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOE—atherosclerosis	1.22e-05	9.69e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CAV1—atherosclerosis	1.21e-05	9.6e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOA1—atherosclerosis	1.21e-05	9.58e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.2e-05	9.56e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.2e-05	9.53e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SCARB1—atherosclerosis	1.2e-05	9.5e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.17e-05	9.31e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.16e-05	9.22e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SERPINE1—atherosclerosis	1.14e-05	9.08e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.14e-05	9.03e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMGCR—atherosclerosis	1.13e-05	8.97e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3CG—atherosclerosis	1.1e-05	8.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—FABP4—atherosclerosis	1.09e-05	8.67e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LCAT—atherosclerosis	1.09e-05	8.67e-05	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.09e-05	8.67e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS3—atherosclerosis	1.09e-05	8.67e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.08e-05	8.55e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOA4—atherosclerosis	1.07e-05	8.51e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LIPC—atherosclerosis	1.07e-05	8.49e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPARG—atherosclerosis	1.06e-05	8.44e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOC3—atherosclerosis	1.06e-05	8.44e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LDLR—atherosclerosis	1.06e-05	8.39e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.05e-05	8.36e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—INS—atherosclerosis	1.04e-05	8.28e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CETP—atherosclerosis	1.03e-05	8.19e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.03e-05	8.14e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.02e-05	8.09e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.01e-05	8.04e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ABCA1—atherosclerosis	1.01e-05	8e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—atherosclerosis	9.99e-06	7.93e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SCARB1—atherosclerosis	9.89e-06	7.85e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.74e-06	7.73e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALB—atherosclerosis	9.56e-06	7.59e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMGCR—atherosclerosis	9.34e-06	7.41e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.23e-06	7.33e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.23e-06	7.33e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOA2—atherosclerosis	9.23e-06	7.33e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.23e-06	7.33e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NOS3—atherosclerosis	9.15e-06	7.26e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.12e-06	7.24e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—atherosclerosis	8.82e-06	7e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LPA—atherosclerosis	8.81e-06	6.99e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMOX1—atherosclerosis	8.7e-06	6.9e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMOX1—atherosclerosis	8.65e-06	6.86e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—BGN—atherosclerosis	8.53e-06	6.77e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOA5—atherosclerosis	8.44e-06	6.7e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—atherosclerosis	8.37e-06	6.64e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—MAPK3—atherosclerosis	8.35e-06	6.63e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOB—atherosclerosis	8.33e-06	6.61e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.32e-06	6.6e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOB—atherosclerosis	8.28e-06	6.57e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.13e-06	6.45e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.1e-06	6.43e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—atherosclerosis	8.1e-06	6.43e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—atherosclerosis	8.06e-06	6.39e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LPL—atherosclerosis	7.95e-06	6.31e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LPL—atherosclerosis	7.91e-06	6.28e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.85e-06	6.23e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—STAT3—atherosclerosis	7.79e-06	6.18e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GPX1—atherosclerosis	7.76e-06	6.16e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GPX1—atherosclerosis	7.72e-06	6.12e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CD36—atherosclerosis	7.56e-06	6e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CD36—atherosclerosis	7.51e-06	5.96e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—MAPK3—atherosclerosis	7.44e-06	5.91e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—atherosclerosis	7.22e-06	5.73e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.16e-06	5.68e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.14e-06	5.67e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—atherosclerosis	7.12e-06	5.65e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.04e-06	5.59e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARA—atherosclerosis	7.03e-06	5.58e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LIPC—atherosclerosis	7e-06	5.55e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARA—atherosclerosis	6.99e-06	5.54e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—atherosclerosis	6.97e-06	5.53e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOC3—atherosclerosis	6.95e-06	5.52e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LDLR—atherosclerosis	6.91e-06	5.48e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOB—atherosclerosis	6.84e-06	5.43e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AGT—atherosclerosis	6.8e-06	5.4e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AGT—atherosclerosis	6.77e-06	5.37e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CETP—atherosclerosis	6.75e-06	5.36e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOE—atherosclerosis	6.67e-06	5.29e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.65e-06	5.28e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOE—atherosclerosis	6.63e-06	5.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CAV1—atherosclerosis	6.61e-06	5.24e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOA1—atherosclerosis	6.59e-06	5.23e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CAV1—atherosclerosis	6.57e-06	5.21e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOA1—atherosclerosis	6.55e-06	5.2e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LPL—atherosclerosis	6.53e-06	5.18e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.46e-06	5.13e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GPX1—atherosclerosis	6.37e-06	5.06e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CD36—atherosclerosis	6.2e-06	4.92e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.1e-06	4.84e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.02e-06	4.78e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3CG—atherosclerosis	5.98e-06	4.75e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.88e-06	4.67e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARG—atherosclerosis	5.81e-06	4.61e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARG—atherosclerosis	5.77e-06	4.58e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARA—atherosclerosis	5.77e-06	4.58e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—INS—atherosclerosis	5.7e-06	4.52e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—INS—atherosclerosis	5.66e-06	4.49e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—atherosclerosis	5.63e-06	4.47e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AGT—atherosclerosis	5.59e-06	4.43e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOE—atherosclerosis	5.47e-06	4.34e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—atherosclerosis	5.44e-06	4.32e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.44e-06	4.32e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CAV1—atherosclerosis	5.42e-06	4.3e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOA1—atherosclerosis	5.41e-06	4.29e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALB—atherosclerosis	5.22e-06	4.14e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—atherosclerosis	5.02e-06	3.98e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NOS3—atherosclerosis	4.99e-06	3.96e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NOS3—atherosclerosis	4.97e-06	3.94e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.94e-06	3.92e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARG—atherosclerosis	4.77e-06	3.78e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—INS—atherosclerosis	4.68e-06	3.71e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.67e-06	3.7e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.57e-06	3.63e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—atherosclerosis	4.54e-06	3.61e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOB—atherosclerosis	4.47e-06	3.55e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.35e-06	3.45e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALB—atherosclerosis	4.29e-06	3.4e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LPL—atherosclerosis	4.27e-06	3.39e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—atherosclerosis	4.2e-06	3.34e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPX1—atherosclerosis	4.17e-06	3.31e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NOS3—atherosclerosis	4.1e-06	3.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CD36—atherosclerosis	4.06e-06	3.22e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.84e-06	3.05e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARA—atherosclerosis	3.77e-06	2.99e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.75e-06	2.98e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AGT—atherosclerosis	3.65e-06	2.9e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOE—atherosclerosis	3.58e-06	2.84e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CAV1—atherosclerosis	3.55e-06	2.81e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOA1—atherosclerosis	3.54e-06	2.81e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.23e-06	2.56e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARG—atherosclerosis	3.12e-06	2.47e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—INS—atherosclerosis	3.06e-06	2.43e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALB—atherosclerosis	2.8e-06	2.22e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NOS3—atherosclerosis	2.68e-06	2.13e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.45e-06	1.95e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—atherosclerosis	2.3e-06	1.82e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—atherosclerosis	2.28e-06	1.81e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—atherosclerosis	1.88e-06	1.5e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—atherosclerosis	1.23e-06	9.78e-06	CbGpPWpGaD
